
Antonio Calles/ruberinternacional.es
Mar 26, 2025, 13:38
Antonio Calles: Final overall survival of MARIPOSA trial
Antonio Calles, Head of the Lung Cancer Unit at Ruber International Hospital, shared a post on X:
“Prof Yang presents final overall survival of MARIPOSA trial.
HR 0.75 (95% CI 0.61-0.92) Osimertinib 36.7 months vs not reached for Amivantamab and lazertinib.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 12:32
Mar 29, 2025, 12:06
Mar 29, 2025, 12:00
Mar 29, 2025, 11:58
Mar 29, 2025, 11:36
Mar 29, 2025, 11:26
Mar 29, 2025, 11:03